Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Endo Int'l Plc (ENDP) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 2,935,290
  • Shares Outstanding, K 222,770
  • Annual Sales, $ 3,269 M
  • Annual Income, $ -1,495 M
  • 36-Month Beta 0.62
  • Price/Sales 0.76
  • Price/Book 0.48

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.68 +1.03%
on 01/18/17
17.99 -28.79%
on 01/04/17
-3.23 (-20.14%)
since 12/20/16
3-Month
12.68 +1.03%
on 01/18/17
21.87 -41.43%
on 10/25/16
-7.72 (-37.60%)
since 10/20/16
52-Week
12.56 +1.99%
on 05/12/16
61.14 -79.05%
on 01/26/16
-42.27 (-76.74%)
since 01/20/16

Most Recent Stories

More News
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again

Drug stocks were hit once again with President-elect Donald Trump's comments about the sector at his first news conference since his election in November.

Endo Pharmaceuticals, Inc. Proposed Class Action Settlement for Persons and Entities Who Purchased and/or Paid for Multi-Vitamin with Fluoride Chewable Tablets is announced by Buckner + Miles and McCabe Rabin PA

If You Purchased and/or Paid for Multi-Vitamin with Fluoride Chewable Tablets

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Endo International PLC (ENDP) and Lead Plaintiff Deadline - January 6, 2017

NEW YORK, NY / ACCESSWIRE / January 4, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed against Endo International PLC ("Endo" or the "Company")...

Implied Volatility Surging for Endo International (ENDP) Stock Options

Options traders are pricing in a big move for Endo International (ENDP) shares as it has huge implied volatility.

Endo International (ENDP): Can the Stock Rebound in 2017?

Can Endo make a comeback in 2017 seeing that the company is presently in the middle of the drug pricing controversy?

ENDP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of January 6, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International...

January 6 Deadline Alert: Law Offices of Howard G. Smith Reminds Endo International plc Investors of Upcoming Lead Plaintiff Deadline and Encourages Investors to Contact the Firm

Law Offices of Howard G. Smith reminds investors of the upcoming January 6, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased...

GPM Reminds Investors of the January 6th Deadline in the Class Action Lawsuit Against Endo International plc and Encourages Investors to Contact the Firm

Glancy Prongay & Murray LLP ("GPM") reminds investors of the January 6, 2017 deadline to file a lead plaintiff motion in the class action lawsuit filed on behalf of investors who purchased...

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 6, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Endo International plc To Contact The Firm - ENDP

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of...

ENDP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of January 6, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Endo International plc (NASDAQ:ENDP)...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova,...

See More

Support & Resistance

2nd Resistance Point 13.52
1st Resistance Point 13.21
Last Price 12.81
1st Support Level 12.73
2nd Support Level 12.56

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.